株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のHIV・エイズ検査市場

Global HIV-AIDS Testing Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 301115
出版日 ページ情報 英文 99 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
世界のHIV・エイズ検査市場 Global HIV-AIDS Testing Market 2014-2018
出版日: 2014年04月25日 ページ情報: 英文 99 Pages
概要

エイズとは人体の免疫機能の段階的低下によって引き起こされる病気であり、この免疫力の低下は、HIVと呼ばれるウイルスが白血球、なかでもCD4あるいはヘルパーT細胞と呼ばれる亜集団を攻撃することで引き起こされます。エイズ/HIV検査製品は、血液中のHIVの有無を確認するための医療製品です。これにはHIV抗体検査、抗原(P24)検査、PCR検査などを含む多くの種類があります。世界のHIV・エイズ検査市場は2013年から2018年にかけて、5.43%の変平均成長率で推移すると予測されています。

当レポートでは、世界のHIV・エイズ検査市場の現状と見通しについて調査分析し、現在の市場環境、検査タイプ・地域区分別の動向、検査製品の購入基準、市場成長への影響因子、競合環境、市場シェア、主要ベンダーの企業データ、事業戦略などをまとめ、概略以下の構成でお届けいたします。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 HIVとエイズの概要

  • HIVのタイプ

第6章 イントロダクション

第7章 市場環境

  • 市場概要
  • 市場規模・予測
  • ファイブフォース分析

第8章 市場区分:カテゴリー別

  • 世界のHIV・エイズ検査市場:カテゴリー別

第9章 HIV検査のタイプ

  • 抗体検査
  • 抗原検査
  • PCR検査

第10章 地域区分

  • 世界のHIV・エイズ検査市場:地域分別

第11章 HIV感染者人口の多い国トップ20カ国

第12章 購入基準

第13章 市場成長推進因子

第14章 成長推進因子とその影響

第15章 市場における課題

第16章 成長推進因子および課題の影響

第17章 市場動向

第18章 市場動向とその影響

第19章 ベンダー環境

  • 競合シナリオ
    • 主なニュース
    • M&A
    • 市場シェア分析
    • 他の注目ベンダー

第20章 主要ベンダーの分析

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Hologic Inc.
  • Ortho-Clinical Diagnostics Inc.
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics Inc.
    • 主要データ
    • 事業概要
    • 重要情報
    • 事業戦略
    • SWOT分析、など

第21章 本シリーズの他のレポート

目次
Product Code: IRTNTR3468

About HIV-AIDS Testing

AIDS is a condition caused due to the gradual weakening of the human body's immune system. This weakening is caused by a virus called HIV, which attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. AIDS/HIV testing devices are medical devices that are used to determine the presence of HIV in human blood. A number of testing devices are available including the HIV antibody test, the Antigen (P24) test, and the PCR test.

TechNavio's analysts forecast the Global HIV-AIDS Testing market will grow at a CAGR of 5.43 percent over the period 2013-2018.

Covered in this Report

The Global HIV-AIDS Testing market can be divided into three segments: HIV-AIDS Screening Assays, HIV-AIDS Confirmatory Assays, and HIV-AIDS Monitoring Assays.

TechNavio's report, the Global HIV-AIDS Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global HIV-AIDS Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Hologic Inc.
  • Ortho-Clinical Diagnostics Inc.
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics Inc.

Other Prominent Vendors

  • bioMerieux SA
  • Calypte Biomedical Corp.
  • Fujirebio Diagnostics Inc.
  • Medical Services International Inc.
  • MedMira Laboratories Inc.
  • OraSure Technologies Inc.
  • Quest Diagnostics Inc.
  • Trinity Biotech plc

Market Driver

  • Increase in Number of People Prone to HIV/AIDS.

For a full, detailed list, view our report.

Market Challenge

  • Intense Competition among Vendors.

For a full, detailed list, view our report.

Market Trend

  • Adoption of AIDS/HIV Workplace Policies by Companies.

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. HIV and AIDS Overview

  • 05.1.1. Types of HIV

06. Introduction

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Category

  • 08.1. Global HIV-AIDS Testing Market by Category

09. Types of HIV Tests

  • 09.1.1. Antibody Tests
  • 09.1.2. Antigen Tests
  • 09.1.3. PCR Tests

10. Geographical Segmentation

  • 10.1. Global HIV-AIDS Testing Market by Geographical Segmentation

11. Top 20. Countries with HIV Infected Population

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Share Analysis 2013
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Abbott Laboratories
    • 20.1.1. Key Facts
    • 20.1.2. Business Description
    • 20.1.3. Business Segmentation
    • 20.1.4. Business Strategy
    • 20.1.5. Revenue Segmentation
    • 20.1.6. Revenue Comparison 2012 and 2011
    • 20.1.7. Geographical Segmentation
    • 20.1.8. Key Information
    • 20.1.9. SWOT Analysis
    • 20.1.10. Strengths
    • 20.1.11. Weakness
    • 20.1.12. Opportunities
    • 20.1.13. Threats
  • 20.2. Bio-Rad Laboratories Inc.
    • 20.2.1. Key Facts
    • 20.2.2. Business Description
    • 20.2.3. Business Segmentation
    • 20.2.4. Business Strategy
    • 20.2.5. Revenue Segmentation of Bio-Rad Laboratories Inc.
    • 20.2.6. Revenue Comparison FY2012 and FY2011
    • 20.2.7. Bio-Rad Laboratories Inc. by Geographical Segmentation
    • 20.2.8. Key Information
    • 20.2.9. SWOT Analysis
    • 20.2.10. Strengths
    • 20.2.11. Weakness
    • 20.2.12. Opportunities
    • 20.2.13. Threats
  • 20.3. Hologic Inc.
    • 20.3.1. Key Facts
    • 20.3.2. Business Description
    • 20.3.3. Business Segmentation
    • 20.3.4. Business Strategy
    • 20.3.5. Revenue Segmentation
    • 20.3.6. Revenue Comparison FY2012 and FY2013
    • 20.3.7. Geographical Segmentation
    • 20.3.8. Key Information
    • 20.3.9. SWOT Analysis
    • 20.3.10. Strengths
    • 20.3.11. Weaknesses
    • 20.3.12. Opportunities
    • 20.3.13. Threats
  • 20.4. Ortho-Clinical Diagnostics Inc.
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Key Information
    • 20.4.4. SWOT Analysis
    • 20.4.5. Strengths
    • 20.4.6. Weakness
    • 20.4.7. Opportunities
    • 20.4.8. Threats
  • 20.5. Roche Diagnostics
    • 20.5.1. Key Facts
    • 20.5.2. Business Description
    • 20.5.3. Business Segmentation
    • 20.5.4. Revenue Segmentation
    • 20.5.5. Geographical Segmentation
    • 20.5.6. Business Strategy
    • 20.5.7. Key Information
    • 20.5.8. SWOT Analysis
    • 20.5.9. Strengths
    • 20.5.10. Weaknesses
    • 20.5.11. Opportunities
    • 20.5.12. Threats
  • 20.6. Siemens Healthcare Diagnostics Inc.
    • 20.6.1. Key Facts
    • 20.6.2. Business Overview
    • 20.6.3. Key Information
    • 20.6.4. Business Strategy
    • 20.6.5. SWOT Analysis
    • 20.6.6. Strengths
    • 20.6.7. Weaknesses
    • 20.6.8. Opportunities
    • 20.6.9. Threats

21. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global HIV-AIDS Testing Market Overview
  • Exhibit 3: Global HIV-AIDS Testing market 2013-2018 (US$ billion)
  • Exhibit 4: Global HIV-AIDS Testing Market Segmentation by Category
  • Exhibit 5: Global HIV-AIDS Testing Market Segmentation by Category 2013
  • Exhibit 6: Types of HIV Tests
  • Exhibit 7: Global HIV-AIDS Testing Market by Geographical Segmentation 2013
  • Exhibit 8: Top 20 HIV Infected Countries with HIV Infected Population 2012
  • Exhibit 9: Business Segmentation of Abbott Laboratories
  • Exhibit 10: Revenue Segmentation of Abbott Laboratories 2012
  • Exhibit 11: Revenue Comparison 2012 and 2011 (US$ million)
  • Exhibit 12: Abbott Laboratories by Geographical Segmentation 2012
  • Exhibit 13: Business Segmentation of Bio-Rad Laboratories Inc.
  • Exhibit 14: Revenue Segmentation of Bio-Rad Laboratories Inc. FY2012
  • Exhibit 15: Revenue Comparison 2012 and 2011(US$ million)
  • Exhibit 16: Bio-Rad Laboratories Inc. by Geographical Segmentation 2012
  • Exhibit 17: Business Segmentation of Hologic Inc.
  • Exhibit 18: Revenue Segmentation of Hologic Inc. 2013
  • Exhibit 19: Revenue Comparison FY2012 and FY2013 (US$ million)
  • Exhibit 20: Hologic Inc. by Geographical Segmentation 2013
  • Exhibit 21: Business Segmentation of Roche Diagnostics
  • Exhibit 22: Revenue Segmentation of Roche Diagnostics FY2013
  • Exhibit 23: Roche Diagnostics by Geographical Segmentation FY2013
Back to Top